NORTHWEST BIOTHERAPEUTICS INC
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 302.7% | -1,539.0% | -151.6% |
| FY2017 | 108.6% | 203.7% | -149.6% |
| FY2018 | 74.4% | 114.2% | -145.1% |
| FY2019 | 46.2% | 64.4% | -195.5% |
| FY2020 | 146.0% | 152.2% | -1,610.4% |
| FY2021 | -144.5% | -195.6% | 446.0% |
| FY2022 | 82.0% | 98.6% | -335.3% |
| FY2023 | 95.2% | 250.6% | -224.7% |
| FY2024 | 88.7% | 263.4% | -313.4% |
| FY2025 | 99.8% | 25,278.2% | -74.0% |